Nexstim Plc (NXTMH.HE)
Nexstim Plc operates in the Medical - Devices industry of the Healthcare sector, headquartered in Helsinki, FI. The stock last traded at $9.64, up 1.69% on the session, giving a market capitalisation of $69.7M. Its beta of 0.44 implies it has historically moved less than the broad market.
Nexstim Plc, a medical technology enterprise, specializes in the creation and global distribution of non-invasive brain stimulation technologies, with operations spanning Finland, Europe, North America, and other international markets. Central to its offerings is the proprietary SmartFocus technology, featuring 3D navigation, which underpins its navigated transcranial magnetic stimulation (TMS) approach utilized for both therapeutic interventions and diagnostic assessments. The company provides two distinct systems: the NBT system, a navigated brain therapy solution designed for addressing major depression and chronic neuropathic pain, and the NBS system, a navigated brain stimulation device engineered for precise pre-surgical mapping of the brain's speech and motor cortices. Nexstim predominantly sells its NBS systems to academic institutions and teaching hospitals. Established in 2000, Nexstim Plc's corporate headquarters are located in Helsinki, Finland.
Nexstim Plc is most often compared with the following Healthcare names: